Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer

Sponsor
First Affiliated Hospital Xi'an Jiaotong University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06017271
Collaborator
(none)
160
1
9
17.8

Study Details

Study Description

Brief Summary

The occurrence and progression of lung cancer is related to visceral adipose tissue (VAT). Epicardial adipose tissue (EAT) is a kind of VAT, producing a variety of inflammatory cytokines and adipokines, participating in the formation of local inflammation, promoting the formation of pre-thrombotic state, and leading to the occurrence of thromboembolism. Patients with lung cancer have increased inflammatory response and are more prone to suffer thrombosis. However, in lung cancer patients, the clinical correlation between EAT and pulmonary embolism has not been reported. Objective: To analyze the risk factors of poor prognosis in lung cancer patients with PE, and to explore the predictive value of EAT in pulmonary embolism events and death in lung cancer patients. Methods: EAT volume and density, as well as anthropometric and blood biomarkers, were evaluated in a sample of lung cancer patients, half with pulmonary embolism and half without. The incidence of adverse prognosis and related factors were followed up by telephone.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: CTPA (computed tomography pulmonary angiography)

Study Design

Study Type:
Observational
Anticipated Enrollment :
160 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Anticipated Study Start Date :
Sep 30, 2023
Anticipated Primary Completion Date :
Oct 30, 2023
Anticipated Study Completion Date :
Jun 30, 2024

Arms and Interventions

Arm Intervention/Treatment
PE group

The CTPA diagnosis suggest pulmonary embolism

Diagnostic Test: CTPA (computed tomography pulmonary angiography)
The CTPA diagnosis suggest or did not suggest pulmonary embolism.

control group

The CTPA diagnosis did not suggest pulmonary embolism

Diagnostic Test: CTPA (computed tomography pulmonary angiography)
The CTPA diagnosis suggest or did not suggest pulmonary embolism.

Outcome Measures

Primary Outcome Measures

  1. EAT volume [May, 20, 2023]

    volume of epicardial adipose tissue (EAT), Cm3

  2. EAT density [May, 20, 2023]

    density of epicardial adipose tissue (EAT) , Hounsfield Units (HU)

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The pathological diagnosis was lung cancer

  • Pulmonary artery was evaluated by CTA during hospitalization.

Exclusion Criteria:
  • Patients with incomplete clinical data

  • Patients with no follow-up data

  • Patients with a history of PE before diagnosis of lung cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 First Affiliated Hospital of Xian Jiaotong University Xi'an Shaanxi China 710061

Sponsors and Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

Investigators

  • Study Director: Yang Yan, First Affiliated Hospital Xi'an Jiaotong University
  • Principal Investigator: Haichen Wang, First Affiliated Hospital Xi'an Jiaotong University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
First Affiliated Hospital Xi'an Jiaotong University
ClinicalTrials.gov Identifier:
NCT06017271
Other Study ID Numbers:
  • XJTU1AF2023LSK-269
First Posted:
Aug 30, 2023
Last Update Posted:
Aug 30, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 30, 2023